1. Home
  2. cancer treatment

CAR-T, Lifesaving Cancer Treatment, May Sometimes Cause Cancer, FDA Says - The New York Times

$ 12.50

4.9 (478) In stock

MY FIRST 100 DAYS AS LLS PRESIDENT & CEO

Why second-line approval of CAR T-cell therapy is needed for blood cancers

Value and affordability of CAR T-cell therapy in the United States

Carl June to Receive 2024 Breakthrough Prize in Life Sciences

NIH Considers Guidelines for CAR-T therapy: Report from Recombinant DNA Advisory Committee

Hailing a breakthrough in fighting cancer, FDA approves gene therapy that functions as a 'living drug' - Los Angeles Times

When Evidence Says No, but Doctors Say Yes - The Atlantic

FDA Approves Novel Car T-Immunotherapy for the Treatment of Multiple Myeloma

Opinion Cancer Drug Advancements Give New Hope to Metastatic Patients - The New York Times

Penn State Cancer Institute offers lifesaving lymphoma treatment - Penn State Health News

First Gene Therapy Approved in U.S., Article

CAR-T cell therapy is the cancer killer the world needs now

Medicare Aims to Expand Coverage of Cancer Care. But Is It Enough? - The New York Times